# Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women.

> **NCT03686085** · PHASE3 · COMPLETED · sponsor: **Cairo University** · enrollment: 200 (actual)

## Conditions studied

- Intrauterine Device

## Interventions

- **DRUG:** Dinoprostone 3 mg
- **DRUG:** placebo vaginal tablet

## Key facts

- **NCT ID:** NCT03686085
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-30
- **Primary completion:** 2019-03-01
- **Final completion:** 2019-03-10
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2020-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03686085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03686085, "Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03686085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*